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 CONCLUSIONS
An association between male and female sex hormones 
and selenium (Se) status has been reported in animals 
and humans. These relationships may be important 
relative to the use of selenium in hormone related 
diseases such as breast cancer. The purpose of this study 
is to examine the effect of estrogen status on the 
absorption, tissue distribution and metabolism of Se. 60 
µCi of  75Se as selenite was orally administered to 
bilaterally ovariectomized rats 5 weeks after 
implantation of either placebo pellet (-E) or pellet with 
estradiol (+E). Blood and tissues were collected 1, 3, 6, 
and 24 h after dosing. Although absorption of  75Se was 
independent of E status, 75Se activity differed (P<0.05) 
in blood, liver, heart, kidney, spleen, brain, and thymus 
at certain times. For example, total 75Se activity in liver 
was greater in -E than in +E rats after 1 hour (13.1% vs. 
3.9% of total dose). However, +E group had greater 75Se 
in liver after 6 h than -E group (18.0% vs. 10.9%). The 
relative distribution of 75Se between cytosol and 
membrane fractions in tissues was independent of E 
status. Nor it affected the relative distribution of 75Se 
among the selenoproteins in cytosol of the above tissues 
and plasma. However, larger percent of  75Se was 
incorporated into selenoprotein P (SeP) and glutathione 
peroxidase (GPx) in plasma in +E group at 3, 6 and 24 h 
compared to -E group (P<0.05). These results suggest 
that the effects of estrogen status on selenium 
distribution among tissues are tissue specific and time-
dependent. (Supported by the OARDC Grant 
OHO00201). 
 ABSTRACT
 INTRODUCTION
•Selenium (Se) is an essential nutrient.
•Relationships between gender/sex hormones and 
selenium status have been observed in animals and 
humans. 
•Preliminary findings from our laboratory strongly 
support a relationship between selenium metabolism and 
estrogen status. 
•We hypothesize that the estrogen status will affect  
metabolism of ingested Se.  
•The objective of this study is to examine the effect of 
estrogen status on the absorption, tissue distribution and 
metabolism of  Se in a rat model.
•The results of this study are important when making 
recommendations about Se supplementation to people 
with hormone related diseases such as breast cancer. 
• Hill KE et al.  J. Biol. Chem. 2003; 278 (16): 13640-6.
• Burk RF et al.  J. Nutr. 2003; 133: 1517s-1520s.
• Smith AM  et al.  Nutr Res 1995;15:267-77.
• Behne D  et al. Biochimica et Biophysica Acta 1990; 1033: 219-25
•Estrogen triggers 75Se transported into liver from 1 to 6 hour, and facilitated 75Se distribution 
into other tissues from the liver after 6 hour.  This suggests that estrogen could affect Se 
distribution among tissues by affecting Se metabolism in liver.
•The decrease in plasma SeP from 6 to 24 h suggests that SeP was delivering 75Se to other tissues.
•Estrogen affected Se distribution among some tissues in a time-dependent manner.
•The mechanisms by which estrogen affects the Se metabolism remains to be elucidated.
The authors gratefully acknowledge support of the Ohio 
Agricultural Research and Development Center (OARDC). 
SD female rats (7 wks of age)
Ovariectomized + Placebo (-E, n=16)
Ovariectomized + E2 (+E, n=16) 5 wks
Administered 60 µCi  of  
75Se-selenite  by gavage 
at 12 wks of age
Collect blood and 
tissues 1, 3, 6, 24 h 
after dosing
Measure 75Se 
activity in  blood 
and tissues 
Cytosol fraction
Membrane fraction
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SDS-PAGE
Gels were sliced according to 
known molecular weight of 
selenoproteins and the 75Se 
activity of the gel slices was 
measured
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Figure 1. 75Se activity in blood and liver
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Figure 2. 75Se activity in heart and brain
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*  P<0.05 for a t-test between -E and +E group in figures 1-5
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Figure 3. 75Se activity in spleen and thymus
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Figure 4. 75Se activity among proteins in liver cytosol at 6 h
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Figure 5. 75Se  activity in plasma SeP
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